⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203460 | 1.00 | — | — | |
| SCHEMBL242920 | 1.00 | — | — | |
| SCHEMBL10588899 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1266793 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28683389 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL3403057 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL641358 | 0.97 | — | — | |
| SCHEMBL10588550 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL555933 | 0.97 | — | — | |
| Bromide SCHEMBL7114687 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661941-B1 | THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2022-12-14 | — | — | EP | claimed |
| US-20110053907-A1 | SUBSTITUTED PYRIMIDINES AND TRIAZINES AND THEIR USE IN CANCER THERAPY | AUCKLAND UNISERVICES LIMITED (NZ) | 2011-03-03 | — | — | US | claimed |
| EP-0638068-B1 | PROCESS FOR THE MANUFACTURE OF (S)-3-AMINO-1-SUBSTITUTED-PYRROLIDINES | WARNER LAMBERT CO (US) | 1999-06-23 | — | — | EP | claimed |
| EP-4687443-A1 | METHOD FOR FUNCTIONALISING A SOLID SUBSTRATE WITH A PEPTIDE CONJUGATE | Genepep (FR) | 2026-02-11 | — | — | EP | disclosed |
| EP-3256576-B1 | MIXTURE OF PURIFIED SODS OF PLANT ORIGIN | BIONOV (FR) | 2026-01-28 | — | — | EP | disclosed |
| US-12466815-B2 | Carboxamide compounds and uses thereof | INCYTE CORPORATION (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4620955-A1 | MC4R ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL USE THEREOF | Changchun Genescience Pharmaceutical Co., Ltd. (CN) | 2025-09-24 | — | — | EP | disclosed |
| EP-3541809-B1 | NOVEL SUBSTITUTED N-(3-FLUOROPROPYL)-PYRROLIDINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF | SANOFI SA (FR) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024208878-A1 | METHOD FOR FUNCTIONALISING A SOLID SUBSTRATE WITH A PEPTIDE CONJUGATE | GENEPEP (FR) | 2024-10-10 | — | — | WO | disclosed |
| CN-115974746-B | Synthesis method of tosufloxacin tosylate intermediate | 天地恒一制药股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20240150326-A1 | CARBOXAMIDE COMPOUNDS AND USES THEREOF | INCYTE CORPORATION | 2024-05-09 | — | — | US | disclosed |
| EP-0486687-A1 | QUINOLONECARBOXYLIC ACID DERIVATIVES | SS PHARMACEUTICAL CO., LTD. (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-5061712-A | BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1991-10-29 | — | — | US | disclosed |
| EP-0401623-A1 | Process for the preparation of 7-(3-amino- and 3-aminomethyl-1-pyrrolidinyl)-3-quinolinonecarboxylic and -naphthyridinonecarboxylic acids | BAYER AG (DE) | 1990-12-12 | — | — | EP | disclosed |
| US-4968800-A | Novel platinum complex, antineoplastic agent containing the same, and intermediate therefor | KANEBO LIMITED (JP) | 1990-11-06 | — | — | US | disclosed |
| US-4965273-A | Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents | BRISTOL-MYERS COMPANY (US) | 1990-10-23 | — | — | US | disclosed |
| EP-0391169-A2 | Enantiomeric pure 7-(3-amino-1-pyrrolidinyl)-chinolon-and-naphthyridon carboxylic acids | BAYER AG (DE) | 1990-10-10 | — | — | EP | disclosed |
| CN-1045972-A | 5-replaces-1,4-dihydro-4-oxo-naphthyridine-3-carboxylic acid (ester) antimicrobial drug | BRISTOL MYERS SQUIBB CO (US) | 1990-10-10 | — | — | CN | disclosed |
| US-4939256-A | Novel platinum complex, antineoplastic agent containing the same, and intermediate therefor | KANEBO LTD. (JP) | 1990-07-03 | — | — | US | disclosed |
| EP-0327709-A2 | Novel platinum complex, antineoplastic agent containing the same, intermediate therefor, preparation method and use | KANEBO LTD. (JP) | 1989-08-16 | — | — | EP | disclosed |